Diane van der Vliet

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

Maria Rosario Capeding, Ngoc Huu Tran, Sri Rezeki Hadinegoro et al. · The Lancet · 2014 · 959 citations

Vaccination, Vaccine Safety, Global Health +8

Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials

Sophia Gailhardou, Anna Skipetrova, Gustavo H. Dayan et al. · PLoS neglected tropical diseases · 2016 · 52 citations · Full text

Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy

Maia A. Rabaa, Yves Girerd-Chambaz, Kien Duong Thi Hue et al. · eLife · 2017 · 52 citations · Full text

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

Odile Launay, Christine Sadorge, Nathalie Jolly et al. · Vaccine · 2009 · 44 citations

Vaccination, Vaccine Safety, Vaccine Development +7

Safety and Immunogenicity of Yellow Fever 17D Vaccine in Adults Receiving Systemic Corticosteroid Therapy: An Observational Cohort Study

Solen Kernéis, Odile Launay, Thierry Ancelle et al. · Arthritis Care & Research · 2013 · 43 citations